Sort
48,018 grants matching “immunotherapy”
Augmented Transgenic TCR-mediated tumor therapy
$742,305Aude Chapuis · University Of Washington · P01 · FY2025 · CA
Baltimore Pediatric AIDS Clinical Trials Group
$742,005Johns Hopkins University · U01 · FY2003 · AI
Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function
$741,926Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2024 · GM
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections
$741,917Mariette Barbier · West Virginia University · R01 · FY2024 · AI
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$741,840David P Carbone · Ohio State University · R01 · FY2025 · CA
T CELL AUTOIMMUNITY
$741,801Washington University · P01 · FY2001 · AI
Programming T Cell Fates for Therapeutic Use
$741,566Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev
$741,390Yvonne J Rosenberg · Plantvax, Inc. · R44 · FY2012 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$741,289James D. Marks · University Of California, San Francisco · U01 · FY2010 · AI
ISLET TOLERANCE INDUCTION BASED ON ANTI-CD154 ANTIBODY
$741,180Univ Of Massachusetts Med Sch Worcester · R01 · FY2001 · DK
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$741,074Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$741,049Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Administrative Core
$741,000Jun Yan · University Of Louisville · P20 · FY2020 · GM
PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments
$740,955Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2024 · CA
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$740,622Karl T Kelsey · Brown University · R01 · FY2021 · CA
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
$740,564Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2021 · AI
Imaging
$740,483Daniel P Barboriak · Duke University · P01 · FY2014 · CA
The Antigen Targeting Core
$740,468Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
City of Hope Clinical Oncology Career Research Development Program
$740,319Joanne E. Mortimer · Beckman Research Institute/City Of Hope · K12 · FY2010 · CA
THERAPY OF CML
$740,244University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$740,152Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Regulation of human dendritic cell activation
$739,908Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$739,895John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$739,895John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
$739,678David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2007 · AI